Variables | Crude HR and 95% CI | p-value | Model 1a Adjusted HR and 95% CI | p-value | Model 2b Adjusted HR and 95% CI | p-value |
---|---|---|---|---|---|---|
Diabetic neuropathy, yes | 0.6 (0.53–0.67) | < 0.001 | 0.79 (0.7–0.89) | < 0.001 | 0.79 (0.68–0.92) | 0.002 |
Coronary artery disease, yes | 1.95 (1.82–2.09) | < 0.001 | 1.06 (0.99–1.14) | 0.096 | 1.41 (1.27–1.55) | < 0.001 |
Hypertensionyes | 1.39 (1.3–1.49) | < 0.001 | 0.68 (0.64–0.73) | < 0.001 | 0.51 (0.46–0.56) | < 0.001 |
Diabetic nephropathy, yes | 1.92 (1.73–2.12) | < 0.001 | 1.71 (1.54–1.89) | < 0.001 | 2.13 (1.9–2.39) | < 0.001 |
Retinopathy, yes | 0.53 (0.46–0.6) | < 0.001 | 0.75 (0.66–0.86) | < 0.001 | 0.68 (0.57–0.8) | < 0.001 |
Stroke, yes | 3.0 (2.66–3.41) | < 0.001 | 1.67 (1.47–1.89) | < 0.001 | 1.7 (1.49–1.94) | < 0.001 |
Diabetic foot, yes | 2.31 (2.13–2.5) | < 0.001 | 1.13 (1.04–1.23) | 0.004 | 0.98 (0.88–1.09) | 0.689 |
Amputations, yes | 3.44 (3.12–3.81) | < 0.001 | 1.33 (1.2–1.48) | < 0.001 | 1.23 (1.07–1.4) | 0.002 |
Neoplasms, yes | 1.27 (1.12–1.44) | < 0.001 | 1.32 (1.17–1.5) | < 0.001 | 1.28 (1.13–1.45) | < 0.001 |